Rothschild Investment Corp IL decreased its position in CVS Health Corp (NYSE:CVS) by 55.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 98,596 shares of the pharmacy operator’s stock after selling 123,534 shares during the quarter. Rothschild Investment Corp IL’s holdings in CVS Health were worth $6,218,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of the company. Successful Portfolios LLC acquired a new position in shares of CVS Health in the third quarter valued at approximately $260,000. Northside Capital Management LLC grew its position in shares of CVS Health by 5.9% in the third quarter. Northside Capital Management LLC now owns 12,308 shares of the pharmacy operator’s stock valued at $776,000 after purchasing an additional 690 shares during the last quarter. CLARET ASSET MANAGEMENT Corp grew its position in shares of CVS Health by 3.5% in the third quarter. CLARET ASSET MANAGEMENT Corp now owns 128,319 shares of the pharmacy operator’s stock valued at $8,093,000 after purchasing an additional 4,397 shares during the last quarter. Carlton Hofferkamp & Jenks Wealth Management LLC grew its position in shares of CVS Health by 1.5% in the third quarter. Carlton Hofferkamp & Jenks Wealth Management LLC now owns 13,255 shares of the pharmacy operator’s stock valued at $824,000 after purchasing an additional 201 shares during the last quarter. Finally, Rockland Trust Co. grew its position in shares of CVS Health by 3.1% in the third quarter. Rockland Trust Co. now owns 271,908 shares of the pharmacy operator’s stock valued at $16,647,000 after purchasing an additional 8,198 shares during the last quarter. 75.91% of the stock is currently owned by institutional investors.
CVS has been the topic of several research reports. ValuEngine raised CVS Health from a “strong sell” rating to a “sell” rating in a research report on Wednesday, October 2nd. TheStreet raised CVS Health from a “c+” rating to a “b-” rating in a research report on Monday, September 9th. Citigroup increased their price target on CVS Health from $68.00 to $72.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Cowen reissued an “outperform” rating and set a $76.00 price target (up previously from $69.00) on shares of CVS Health in a research report on Tuesday, August 27th. Finally, Evercore ISI set a $63.00 price target on CVS Health and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Two analysts have rated the stock with a sell rating, seven have given a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the company. CVS Health currently has an average rating of “Buy” and a consensus target price of $75.39.
Shares of CVS traded up $0.80 during trading hours on Friday, reaching $62.94. The stock had a trading volume of 6,278,729 shares, compared to its average volume of 6,237,457. CVS Health Corp has a 12 month low of $51.72 and a 12 month high of $82.15. The stock has a market capitalization of $78.52 billion, a PE ratio of 8.89, a PEG ratio of 1.32 and a beta of 0.86. The company has a debt-to-equity ratio of 1.39, a quick ratio of 0.64 and a current ratio of 0.95. The company’s 50-day moving average is $62.12 and its two-hundred day moving average is $56.71.
CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.89 EPS for the quarter, beating the Zacks’ consensus estimate of $1.70 by $0.19. CVS Health had a return on equity of 16.15% and a net margin of 1.91%. The company had revenue of $63.43 billion during the quarter, compared to analysts’ expectations of $62.66 billion. During the same period in the prior year, the company earned $1.69 EPS. CVS Health’s revenue was up 35.2% compared to the same quarter last year. Equities analysts anticipate that CVS Health Corp will post 6.97 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Monday, November 4th. Stockholders of record on Thursday, October 24th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.18%. The ex-dividend date of this dividend is Wednesday, October 23rd. CVS Health’s payout ratio is 28.25%.
In related news, CFO Eva C. Boratto sold 8,130 shares of the firm’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $65.00, for a total transaction of $528,450.00. Following the completion of the transaction, the chief financial officer now directly owns 55,273 shares of the company’s stock, valued at approximately $3,592,745. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Joshua Matthew Flum sold 17,703 shares of the firm’s stock in a transaction on Monday, September 30th. The stock was sold at an average price of $63.00, for a total value of $1,115,289.00. Following the transaction, the executive vice president now directly owns 36,163 shares of the company’s stock, valued at $2,278,269. The disclosure for this sale can be found here. 0.53% of the stock is currently owned by corporate insiders.
About CVS Health
CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.
Read More: Short Selling Stocks and Day Traders
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.